Cargando…

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases

Inhibitors of the catalytic activity of the 20S proteasome are cytotoxic to tumor cells and are currently in clinical use for treatment of multiple myeloma, whilst the deubiquitinase activity associated with the 19S regulatory subunit of the proteasome is also a valid target for anti-cancer drugs. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Chao, Roboti, Peristera, Puumalainen, Marjo-Riitta, Fryknäs, Mårten, Wang, Xin, D'Arcy, Padraig, Hult, Malin, High, Stephen, Linder, Stig, Swanton, Eileithyia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186810/ https://www.ncbi.nlm.nih.gov/pubmed/25286379 http://dx.doi.org/10.1371/journal.pone.0108839

Ejemplares similares

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition
por: Mazurkiewicz, Magdalena, et al.
Publicado: (2017)

Inhibition of protein translocation at the endoplasmic reticulum promotes activation of the unfolded protein response
por: McKibbin, Craig, et al.
Publicado: (2012)

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
por: Mofers, Arjan, et al.
Publicado: (2019)

Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System
por: Selvaraju, Karthik, et al.
Publicado: (2021)

Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome
por: Bashore, Charlene, et al.
Publicado: (2015)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Proteasome in action: substrate degradation by the 26S proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022)

Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition
por: Dambacher, Corey M, et al.
Publicado: (2016)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex
por: Roboti, Peristera, et al.
Publicado: (2022)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
por: Liu, Ningning, et al.
Publicado: (2014)

Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome
por: Lopez-Castejon, Gloria, et al.
Publicado: (2013)

Thiostrepton interacts covalently with Rpt subunits of the 19S proteasome and proteasome substrates
por: Sandu, Cristinel, et al.
Publicado: (2015)

Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis
por: Lan, Qiuyan, et al.
Publicado: (2021)

OST4 is a subunit of the mammalian oligosaccharyltransferase required for efficient N-glycosylation
por: Dumax-Vorzet, Audrey, et al.
Publicado: (2013)

Deubiquitinase activity is required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress
por: Fang, Nancy N., et al.
Publicado: (2016)

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
por: Vdovin, Alexander, et al.
Publicado: (2022)

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
por: Zhang, Xiaonan, et al.
Publicado: (2020)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

Iron chelators target both proliferating and quiescent cancer cells
por: Fryknäs, Mårten, et al.
Publicado: (2016)

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
por: Xia, Xiaohong, et al.
Publicado: (2018)

Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome
por: Lee, Yun-Tzai Cloud, et al.
Publicado: (2017)

Modelling Proteasome and Proteasome Regulator Activities
por: Liepe, Juliane, et al.
Publicado: (2014)

Deubiquitination Reactions on the Proteasome for Proteasome Versatility
por: Shin, Ji Yeong, et al.
Publicado: (2020)

The Parkinson's disease protein LRRK2 impairs proteasome substrate clearance without affecting proteasome catalytic activity
por: Lichtenberg, M, et al.
Publicado: (2011)

Substrate selection by the proteasome during degradation of protein complexes
por: Prakash, Sumit, et al.
Publicado: (2008)

Conformational switching of the 26S proteasome enables substrate degradation
por: Matyskiela, Mary E., et al.
Publicado: (2013)

Conserved Sequence Preferences Contribute to Substrate Recognition by the Proteasome
por: Yu, Houqing, et al.
Publicado: (2016)

Structural Insights into Substrate Recognition and Processing by the 20S Proteasome
por: Sahu, Indrajit, et al.
Publicado: (2021)

ATP-independent substrate recruitment to proteasomal degradation in mycobacteria
por: von Rosen, Tatjana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_osk6tcru1f31botru8ld99k80d